The government takes aim at prior authorization
Today's story is a single one, but it lands on a nerve nearly every American with health coverage has felt. The federal government is testing whether artificial intelligence can take over one of the most frustrating parts of the U.S. health care system: prior authorization, the process insurers use to approve or deny coverage for treatments.
If you have ever waited days for an insurer to bless a scan, a medication, or a procedure your doctor already recommended, you have met prior authorization. It is the paperwork gate between a treatment being ordered and a treatment being paid for — and it is widely regarded as one of the most hated chores in health care, disliked by patients who wait, by doctors who file, and by the staff who chase approvals on both ends.
Why put AI on this job
Prior authorization is, at its core, a matching problem. A request comes in; rules, coverage terms, and clinical criteria have to be checked against it; a yes or no comes out. That is precisely the kind of high-volume, rules-heavy, document-drowned work where automation tends to promise the most relief. The bet Washington is now placing is that AI can move these decisions faster and lift some of the manual burden that makes the process so grinding for everyone involved.
The appeal is obvious. Speed matters when a delayed approval means a delayed treatment. Volume matters when the sheer number of requests is what clogs the system. If software can triage the routine cases and clear them quickly, the theory goes, both patients and providers get time back.
The stakes beneath the experiment
The same qualities that make prior authorization a tempting target for AI are the ones that make it delicate. This is not a back-office convenience; it is the mechanism that decides whether care gets covered. Automating approvals is one thing. Automating denials — decisions that can keep someone from a treatment their doctor wants — raises the harder questions about oversight, accuracy, and who is accountable when the answer is no.
That the government itself is running the test, rather than leaving it entirely to insurers, is the part worth watching. It signals that prior authorization has graduated from an industry annoyance into a policy problem, and that regulators want a hand in shaping how AI enters a process that touches coverage decisions directly.
The bottom line
For a broad audience, the takeaway is simple: a chore almost everyone resents is now a testbed for artificial intelligence, with the government holding the stopwatch. Whether AI ends up untangling prior authorization or simply speeding up the same frustrations will depend on what these tests actually show. Tonight, the experiment is the news — and it is one to keep an eye on.